Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021

In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Akash, Ashour, Dina, Shebl, Fatma M, Platt, Laura, Chiosi, John J, Nelson, Sandra B, Ard, Kevin L, Kim, Arthur Y, Bassett, Ingrid V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368317/
https://www.ncbi.nlm.nih.gov/pubmed/37496604
http://dx.doi.org/10.1093/ofid/ofad342
_version_ 1785077487312568320
author Gupta, Akash
Ashour, Dina
Shebl, Fatma M
Platt, Laura
Chiosi, John J
Nelson, Sandra B
Ard, Kevin L
Kim, Arthur Y
Bassett, Ingrid V
author_facet Gupta, Akash
Ashour, Dina
Shebl, Fatma M
Platt, Laura
Chiosi, John J
Nelson, Sandra B
Ard, Kevin L
Kim, Arthur Y
Bassett, Ingrid V
author_sort Gupta, Akash
collection PubMed
description In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should consider concurrent HCV treatment during OPAT.
format Online
Article
Text
id pubmed-10368317
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103683172023-07-26 Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021 Gupta, Akash Ashour, Dina Shebl, Fatma M Platt, Laura Chiosi, John J Nelson, Sandra B Ard, Kevin L Kim, Arthur Y Bassett, Ingrid V Open Forum Infect Dis Brief Report In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should consider concurrent HCV treatment during OPAT. Oxford University Press 2023-07-05 /pmc/articles/PMC10368317/ /pubmed/37496604 http://dx.doi.org/10.1093/ofid/ofad342 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Gupta, Akash
Ashour, Dina
Shebl, Fatma M
Platt, Laura
Chiosi, John J
Nelson, Sandra B
Ard, Kevin L
Kim, Arthur Y
Bassett, Ingrid V
Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021
title Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021
title_full Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021
title_fullStr Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021
title_full_unstemmed Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021
title_short Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy—Boston, Massachusetts, 2016–2021
title_sort evaluation of hepatitis c treatment outcomes among patients enrolled in outpatient parenteral antibiotic therapy—boston, massachusetts, 2016–2021
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368317/
https://www.ncbi.nlm.nih.gov/pubmed/37496604
http://dx.doi.org/10.1093/ofid/ofad342
work_keys_str_mv AT guptaakash evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT ashourdina evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT sheblfatmam evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT plattlaura evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT chiosijohnj evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT nelsonsandrab evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT ardkevinl evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT kimarthury evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021
AT bassettingridv evaluationofhepatitisctreatmentoutcomesamongpatientsenrolledinoutpatientparenteralantibiotictherapybostonmassachusetts20162021

Ejemplares similares